Status:
RECRUITING
Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29
Lead Sponsor:
City of Hope Medical Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cutaneous Lymphoma
Eligibility:
All Genders
18+ years
Brief Summary
This study assesses the quality of life in patients with cutaneous lymphoma diagnosis as it relates to their personal, clinical, and therapeutic information using the Skindex29 questionnaire and also ...
Detailed Description
PRIMARY OBJECTIVES: I. To prospectively assess quality of life (QoL) in adult patients with cutaneous lymphoma (CL) via use of a validated questionnaire (Skindex-29) and identify the psychosocial nee...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Agreement to participate in the research study
- Presumed or confirmed diagnosis of CL
Exclusion
Key Trial Info
Start Date :
August 17 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 24 2034
Estimated Enrollment :
1250 Patients enrolled
Trial Details
Trial ID
NCT04670874
Start Date
August 17 2023
End Date
January 24 2034
Last Update
January 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
City of Hope Medical Center
Duarte, California, United States, 91010